treatment was employed. Phospholipids were purchased from Avanti Polar Lipids. The vcsiclcs (at a phospholipid concentration of 1 mg/ml in 30 mM-Tris/HCI buffer, pH 7.0, containing 0 . I M-NaCI) were prepared by sonication for 30 rnin in a water-bath sonifier at tcmperaturcs above the phasc transition of the corresponding phospholipid. The concentration of a-sarcin was determined by absorbance measurements and considcring its extinction coefficient at 280 nm 141. *-Sarcin-phospholipid complexes wcre prepared by adding the protein to freshly prepared vesicles and incubating at 37°C for 60 min. The proteolytic treatment was performed using N-tosyl-1.-phenylalanine chloromethyl ketone-treated trypsin at an enzymc/substrate weight ratio of I :SO. Aliquots were taken at different hydrolysis times, reduced with 3% (v/v) 2-mercaptoethanol and analyscd by 0.1% (w/v) SDS/polyacrylarnide-slab-gel electrophoresis [4'% (w/v) and IS'%, (w/v) acrylamide for the stacking and running gels. respectively]. The absorbance scans at 550 nm (on a Beckman DU-8 spectrophotometer) of the vacuumdried gels (staincd with Coomassic Blue) were used t o calculate the remaining intact protein after the trypsin treatment. The results obtained are given in Fig. 1 . The protein was completely hydrolysed after 24 h of trypsin treatment at 37°C. However. phospholipid vcsiclcs provided an cffcctivc protection for a-sarcin against proteolysis. The percentage of hydrolysis reached a plateau at about 30% protein hydrolysis after about 10 h o f trypsin treatment. Thus, about 70% of the a-sarcin molecules in saturated protein-phospholipid complexes were protected against . proteolysis. The total number o f lysine plus arginine residues in a-sarcin reprcsents about 15% of the total amino acid residues, which cnhanccs the importance of the protection of the whole polypeptide chain against proteolysis caused by the lipid vesicles.
The described interaction between a-sarcin and phospholipid vesicles may be involved directly in the molecular mechanism by which the protein enters tumour cell membranes. shown that repetitive freeze-thaw cycles of MLVs (FT-MLV) can also result in a transmembrane equilibrium of solute concentrations with increased trapping efficiencies. In an attempt to increase the yield of encapsulation in large unilamellar vesicles (LUV), we have compared the encapsulation efficiency of several molecules with different molecular mass and structure in liposomes obtained by extrusion through polycarbonate filters of preformed MLVs (LUV) and FI-MLVs (FT-LUV).
Muteriuls arid methods
The encapsulated material was (molecular mass) : carboxyfluoresccin ( C F 376.3 Da); protein A (40 kDa) and pN2-a-1 AT plasmid (0.3 kbp; a gift from Dr Y. Yamada, Bethesda,
U.S.A.). The phospholipid concentration was determined to
Ahhreviations used: MLV, multilamellar vesicle; LUV, large unilamellar vesicles; FT, freeze-thaw cycle; CF, carboxyfluorescein; PC, phosphatidylcholine. evaluate the encapsulation efficiency [6 1. The entrapped CF was evaluated by fluorimetry. The amount of protein A encapsulated was determined by the inclusion o f '%labelled protein A [7] as tracer. Liposomes containing the pN2-c~-I AT plasmid were disrupted with chloroform and the recovered DNA was evaluated by fluorimetry, using the DNA-binding dye Hoechst 33258 [ 8 ] .
Liposomes were prepared by mechanical resuspension of a previously freeze-dried lipid mixture. This included egg phosphatidylcholine (PC; 30 pmol) and cholesterol (30 pmol) in 2 ml of aqueous phase containing C F ( 2 0 pmol) o r protein A (400 pg) or plasmid (40 pg). Four fractions of 0.5 ml were established. In the first one (MLV), the nonentrapped material was removed by several centrifugations. The second fraction was extruded through polycarbonate filters of 0.2 p m pore size to obtain LUV, under N 2 pressure, and the liposomes were subsequently purified in a Sepharosc 4B column. The rest ( 1 ml) was subjected to five freeze-thaw cycles, utilizing liquid N2 and a 40°C water bath. The third and fourth fractions were then processed as above, to obtain purified FT-MLV and FT-LUV, respectively. In all cases, liposomes containing protein A or plasmid were respectively incubated (1 h at 37°C) with pronase ( 1 mg/ml) or DNAasc I (50 pg/ml in 5 mM-MgCI?) before purification, to rcmove the material associated with the liposome surface.
Results arid disciissiori
FT-MLV were more efficient (2-fold) than MLV in encapsulating CF (Fig. lu) . In addition. we have observed that the yield of C F entrapped in FT-LUV was significantly increased (3-fold) compared with the LUV. These results are in accordance with previous reports in which an increase in the trapped volume was also observed in both FT-MLV I S ] and FT-LUV 101. This suggests that the transmembrane equilibrium of solutes, mediated by the freeze-thaw procedure, could produce an appreciable increase in the aqueous trapped volume as well as in the CF-trapping efficiencies. T h e statistical significance of the yield encapsulation between similar liposomes prepared by both procedures has been evaluated by the Wilcoxon test. * I > < 0.05.
That increased encapsulation of CF is related to particular properties of C F is supported by two additional series of experiments using protein A and the pN2-a-1 AT plasmid (Fig. l b ) . Protein A was also more efficiently encapsulated (2-fold) in FT-MLV than in MLV, but no significant differences were observed between LUV and FT-LUV. In contrast, the freeze-thaw procedure failed to increase the yield of D N A encapsulation in both FT-MLV and FT-LUV liposomes.
In summary, our results suggest that the freeze-thaw procedure increases the encapsulation efficiencies of small molecules such as C F in multi-and uni-lamellar liposomes. but the yield of drug encapsulation may be principally limited by the size and/or structure of the molecules.
